Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 1511 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 1740 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 1761 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 1867 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 1907 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 1982 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 1997 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2029 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2061 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2083 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2113 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2117 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2159 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2260 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2363 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2404 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2410 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2427 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2513 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2525 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2567 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2581 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2610 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2678 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2712 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2906 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2927 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2968 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 2978 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 3007 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 3030 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 3037 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 3067 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 3121 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 3193 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 3316 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 3378 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 3469 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 3728 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 3735 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 4021 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 4033 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 5079 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 5980 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 6029 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 11515 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | 18459 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | No | Borderline Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | No | Borderline Pressures | Male | Cath | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | No | Healthy | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | No | Healthy | Male | Non-invasive | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | No | LowRisk | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | No | LowRisk | Male | Non-invasive | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | No | Normal Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | No | Normal Pressures | Male | Cath | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | No | PAH | Female | Cath | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | No | PAH | Male | Cath | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | Yes | Borderline Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | Yes | Borderline Pressures | Male | Cath | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | Yes | Healthy | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | Yes | Healthy | Male | Non-invasive | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | Yes | LowRisk | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | Yes | LowRisk | Male | Non-invasive | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | Yes | Normal Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | Yes | Normal Pressures | Male | Cath | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | Yes | PAH | Female | Cath | |
Reversed phase NEGATIVE ION MODE | OMEGA-HYDROXYDODECANOIC ACID (M-H)- | Peak area normalized | Yes | PAH | Male | Cath |